Clinical trial
Tolerance and Efficacy of the Swallowable Obalon® Gastric Balloons System in Children With Severe Obesity
NCT02137330 is registered in ClinicalTrials.gov with Bambino Gesù Hospital and Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerance and Efficacy of the Swallowable Obalon® Gastric Balloons System in Children With Severe Obesity
- Lead sponsor
- Bambino Gesù Hospital and Research Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- June 30, 2014
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
altered liver function tests, glycemic intolerance, severe pediatric obesity (bmi > 97° pc -according to centers for disease control and prevention bmi charts-)